List of Excipients in API vilazodone hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing vilazodone hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Allergan Inc | VIIBRYD | vilazodone hydrochloride | 0456-1110 | CELLULOSE, MICROCRYSTALLINE | |
| Allergan Inc | VIIBRYD | vilazodone hydrochloride | 0456-1110 | FD&C RED NO. 40 | |
| Allergan Inc | VIIBRYD | vilazodone hydrochloride | 0456-1110 | LACTOSE MONOHYDRATE | |
| Allergan Inc | VIIBRYD | vilazodone hydrochloride | 0456-1110 | MAGNESIUM STEARATE | |
| Allergan Inc | VIIBRYD | vilazodone hydrochloride | 0456-1110 | POLYETHYLENE GLYCOL | |
| Allergan Inc | VIIBRYD | vilazodone hydrochloride | 0456-1110 | POLYVINYL ALCOHOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing vilazodone hydrochloride
Detailed excipient profiles for vilazodone hydrochloride
Excipient focus: ALUMINUM OXIDE
vilazodone hydrochloride drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | vilazodone hydrochloride | 46708-232 |
| Alembic Pharmaceuticals Inc | vilazodone hydrochloride | 62332-232 |
| >Company | >Ingredient | >NDC |
vilazodone hydrochloride drug variants not containing ALUMINUM OXIDE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
vilazodone hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
vilazodone hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
vilazodone hydrochloride drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | vilazodone hydrochloride | 0480-2045 |
| Cipla USA Inc | vilazodone hydrochloride | 69097-979 |
| Exelan Pharmaceuticals Inc | vilazodone hydrochloride | 76282-544 |
| >Company | >Ingredient | >NDC |
vilazodone hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: FD&C RED NO. 40
vilazodone hydrochloride drug variants containing FD&C RED NO. 40
vilazodone hydrochloride drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
vilazodone hydrochloride drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | vilazodone hydrochloride | 51407-692 |
| Cardinal Health 107 LLC | vilazodone hydrochloride | 55154-4627 |
| Cipla USA Inc | vilazodone hydrochloride | 69097-979 |
| Exelan Pharmaceuticals Inc | vilazodone hydrochloride | 76282-544 |
| >Company | >Ingredient | >NDC |
vilazodone hydrochloride drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
vilazodone hydrochloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | vilazodone hydrochloride | 0480-2045 |
| Apotex Corp | vilazodone hydrochloride | 60505-4372 |
| Novadoz Pharmaceuticals LLC | vilazodone hydrochloride | 72205-260 |
| >Company | >Ingredient | >NDC |
vilazodone hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: LACTOSE MONOHYDRATE
vilazodone hydrochloride drug variants containing LACTOSE MONOHYDRATE
vilazodone hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | vilazodone hydrochloride | 16729-352 |
| Alembic Pharmaceuticals Limited | vilazodone hydrochloride | 46708-232 |
| Alembic Pharmaceuticals Inc | vilazodone hydrochloride | 62332-232 |
| NorthStar RxLLC | vilazodone hydrochloride | 72603-125 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
vilazodone hydrochloride drug variants containing MAGNESIUM STEARATE
vilazodone hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
vilazodone hydrochloride drug variants containing POLYETHYLENE GLYCOL
vilazodone hydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
vilazodone hydrochloride drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | vilazodone hydrochloride | 0480-2045 |
| Alembic Pharmaceuticals Limited | vilazodone hydrochloride | 46708-232 |
| Alembic Pharmaceuticals Inc | vilazodone hydrochloride | 62332-232 |
| >Company | >Ingredient | >NDC |
vilazodone hydrochloride drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 4000
vilazodone hydrochloride drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | vilazodone hydrochloride | 16729-352 |
| Cipla USA Inc | vilazodone hydrochloride | 69097-979 |
| NorthStar RxLLC | vilazodone hydrochloride | 72603-125 |
| Exelan Pharmaceuticals Inc | vilazodone hydrochloride | 76282-544 |
| >Company | >Ingredient | >NDC |
vilazodone hydrochloride drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 8000
vilazodone hydrochloride drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | vilazodone hydrochloride | 60505-4372 |
| Novadoz Pharmaceuticals LLC | vilazodone hydrochloride | 72205-260 |
| >Company | >Ingredient | >NDC |
vilazodone hydrochloride drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYVINYL ALCOHOL
vilazodone hydrochloride drug variants containing POLYVINYL ALCOHOL
vilazodone hydrochloride drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
vilazodone hydrochloride drug variants containing SILICON DIOXIDE
vilazodone hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | vilazodone hydrochloride | 16729-352 |
| NorthStar RxLLC | vilazodone hydrochloride | 72603-125 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
vilazodone hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | vilazodone hydrochloride | 16729-352 |
| Alembic Pharmaceuticals Limited | vilazodone hydrochloride | 46708-232 |
| Alembic Pharmaceuticals Inc | vilazodone hydrochloride | 62332-232 |
| NorthStar RxLLC | vilazodone hydrochloride | 72603-125 |
| >Company | >Ingredient | >NDC |
vilazodone hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: TALC
vilazodone hydrochloride drug variants containing TALC
vilazodone hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
vilazodone hydrochloride drug variants containing TITANIUM DIOXIDE
vilazodone hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
